These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22312812)

  • 1. [Allergy related factors in tears of patients with vernal keratoconjunctivitis undergoing topical 0.1% tacrolimus treatment].
    Hori S; Shoji J; Inada N; Sawa M
    Nippon Ganka Gakkai Zasshi; 2011 Dec; 115(12):1079-85. PubMed ID: 22312812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Usefulness of Simultaneous Measurement of the Tear Levels of CCL17, CCL24, and IL-16 for the Biomarkers of Allergic Conjunctival Disorders.
    Shoji J; Aso H; Inada N
    Curr Eye Res; 2017 May; 42(5):677-684. PubMed ID: 27897453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of eotaxin-1, -2, and -3 protein production and messenger RNA expression in patients with vernal keratoconjunctivitis.
    Shoji J; Inada N; Sawa M
    Jpn J Ophthalmol; 2009 Mar; 53(2):92-99. PubMed ID: 19333691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis.
    Leonardi A; Jose PJ; Zhan H; Calder VL
    Ophthalmology; 2003 Mar; 110(3):487-92. PubMed ID: 12623809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Follow-up study on patients with vernal keratoconjunctivitis undergoing topical 0.1% tacrolimus treatment].
    Harada N; Inada N; Ishimori A; Shoji J; Sawa M
    Nippon Ganka Gakkai Zasshi; 2014 Apr; 118(4):378-84. PubMed ID: 24864437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biomarkers in allergic conjunctival diseases].
    Shoji J
    Arerugi; 2013 Jun; 62(6):641-51. PubMed ID: 23969876
    [No Abstract]   [Full Text] [Related]  

  • 7. Tear cytokine levels in vernal keratoconjunctivitis: the effect of topical 0.05% cyclosporine a therapy.
    Oray M; Toker E
    Cornea; 2013 Aug; 32(8):1149-54. PubMed ID: 23676782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody array-generated cytokine profiles of tears of patients with vernal keratoconjunctivitis or giant papillary conjunctivitis.
    Shoji J; Inada N; Sawa M
    Jpn J Ophthalmol; 2006; 50(3):195-204. PubMed ID: 16767372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of human tear fluid biomarkers in vernal keratoconjunctivitis using iTRAQ quantitative proteomics.
    Leonardi A; Palmigiano A; Mazzola EA; Messina A; Milazzo EM; Bortolotti M; Garozzo D
    Allergy; 2014 Feb; 69(2):254-60. PubMed ID: 24329893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophil cationic protein in tears in allergic conjunctivitis.
    Montan PG; van Hage-Hamsten M
    Br J Ophthalmol; 1996 Jun; 80(6):556-60. PubMed ID: 8759270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Severity and Tear Biomarkers, Eosinophil Cationic Protein and CCL23, in Chronic Allergic Conjunctival Diseases.
    Shoji M; Shoji J; Inada N
    Semin Ophthalmol; 2018; 33(3):325-330. PubMed ID: 27929738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tear eosinophil cationic protein measurement in patients with seasonal allergic conjunctivitis].
    Muromoto K; Shoji J; Inada N; Sawa M; Kato H
    Nippon Ganka Gakkai Zasshi; 2006 Jan; 110(1):13-8. PubMed ID: 16491868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procollagens and inflammatory cytokine concentrations in tarsal and limbal vernal keratoconjunctivitis.
    Leonardi A; Borghesan F; DePaoli M; Plebani M; Secchi AG
    Exp Eye Res; 1998 Jul; 67(1):105-12. PubMed ID: 9702183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the chemokine variation in tears of contact lens wearers].
    Iwasaki Y; Shoji J; Inada N; Sawa M
    Nippon Ganka Gakkai Zasshi; 2006 Sep; 110(9):723-9. PubMed ID: 17025230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokines, matrix metalloproteases, angiogenic and growth factors in tears of normal subjects and vernal keratoconjunctivitis patients.
    Leonardi A; Sathe S; Bortolotti M; Beaton A; Sack R
    Allergy; 2009 May; 64(5):710-7. PubMed ID: 19220217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacrolimus in Corticosteroid-Refractory Vernal Keratoconjunctivitis.
    Chatterjee S; Agrawal D
    Cornea; 2016 Nov; 35(11):1444-1448. PubMed ID: 27310883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of eosinophil cationic protein (ECP) and histamine in vernal keratoconjunctivitis.
    Secchi A; Leonardi A; Abelson M
    Ocul Immunol Inflamm; 1995; 3(1):23-8. PubMed ID: 22827228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophil cationic protein as a marker for assessing the efficacy of tacrolimus ophthalmic solution in the treatment of atopic keratoconjunctivitis.
    Wakamatsu TH; Tanaka M; Satake Y; Dogru M; Fukagawa K; Igarashi A; Fujishima H
    Mol Vis; 2011 Apr; 17():932-8. PubMed ID: 21541276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of lodoxamide, disodium cromoglycate and fluorometholone on tear leukotriene levels in vernal keratoconjunctivitis.
    Akman A; Irkeç M; Orhan M
    Eye (Lond); 1998; 12 ( Pt 2)():291-5. PubMed ID: 9683957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tear Tacrolimus Levels and Clinical Response After Adjunct Therapy With Cutaneous Application of Tacrolimus 0.1% Over Upper Eyelid Skin in Chronic Vernal Keratoconjunctivitis.
    Bardoloi P; Vanathi M; Velpandian T; Laxmi M; Gupta N; Lomi N; Tandon R
    Cornea; 2024 Jul; 43(7):820-827. PubMed ID: 37921523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.